Bristol-Myers Squibb Cancer Moves And Equity Efforts Underpin Valuation Case
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Financing co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as…